Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

Post by Mil_Man54on Oct 13, 2021 3:27pm
184 Views
Post# 34002443

Watched the Presentation

Watched the PresentationNothing impressive, just more of the PR hype......AD never addressed investors directly or indicated how they would restore investor confidence......no plan other than they are "hoping" to start trials at some point......AD was clearly reading from notes and seemed unprepared as he tripped over his words often when he went off script.....he only brought in Dr. Kotra during the Q&A but still did the majority of the talking.......Dr. Kotra said the team was working hard on development yet how are they doing that when they don't have a team and have to hire one......the Q&A were softball questions IMO and I'm guessing from the way his eyes were scanning the screen, the questions were vetted either to remain on topic or weed out the ones where he would be put on the spot or be uncomfortable answering.......compared to the previous presentors, AD struggled and did not present himself as a CEO or confident representative for FSD.....so there you go.....no damage done....but no gains made.....IMO
<< Previous
Bullboard Posts
Next >>